IPA’s 22nd Annual / 22e édition annuelle de l’IPA
GMP UPDATE
BPF Mise à jour
October 6–7, 2026 | Montréal, Canada
6–7 octobre 2026 | Montréal, Canada
Meet Our 2026 Distinguished Speakers & Panelists

Magda Joseph, B.ENG.
Regional Supervisor, GMP & GVP Inspections – East, Superviseure Régionale de l’unité des inspections des médicament et de PSN BPF – Est, Health Canada, Santé Canada

Iuliana Mirbauer
Regional Supervisor ,drogues and NHP GMP Inspections – East, Superviseure Régionale de l’unité des inspections des médicament et de PSN BPF – Est, Health Canada, Santé Canada

Edmond Biba, Ph.D.
Senior Principal Scientist,
General Chapters - Science Division
United States Pharmacopeia

Viorel Buculei, M.Sc., MBA
Quality Control Director,
Jubilant Radiopharma

Nalini Satar, MSc
Country Quality Head,
Bayer Inc.

Kathy Zielinski, MS
AI/ML Compliance Team Lead,
Hoffmann-La Roche Ltd

Jaivik Patel
Site Quality Head, Whitby Site,
PSG-Drug Product Division,
ThermoFisher Scientific

Natasha Demberg, BSc, MSc.
Conference Chair.
President, Demberg Pharma Solutions

Sandrine Benguira
Senior Quality & Compliance Consultant, GMP Consultants Inc.

Stuart Du Kamp
President and Founder, The Quality Consortium

Mathieu Fournier, M.Sc., Chimiste
Chief Scientific Officer, Neopharm Labs

Jon Gawlak
Technical Manager / Senior Auditor, SGS Business Assurance, Pharmaceutical, Cosmetics, and Personal Care (PCPC)

Adam Hazourli
Founder of eBiotech.ai and President of Abrévia Inc.,

Aaron Roth
Director, Project Services
MMR Consulting

Dr. David W. Vincent, B.Sc., MPH, PhD
Chief Scientific Officer (CSO), VTI Life Science